Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (361-370 of 1,833) with videos related to

Pageof 184
Sort By:
Mabs|February 2, 2025
Establishing endotoxin limits to enhance the reliability of in vitro immunogenicity risk assessmentsYun Hee Jeong, Gillian Lennon, Geertruida Veldman, et al.
Mabs|November 15, 2024
Development of a novel, high-throughput imaged capillary isoelectric focusing-Western method to characterize charge heterogeneity of monoclonal antibody heavy and light chainsGangadhar Dhulipala, Alanna Broszeit, Kun Lu, et al.
Mabs|November 29, 2024
Humatch - fast, gene-specific joint humanisation of antibody heavy and light chainsLewis Chinery, Jeliazko R Jeliazkov, Charlotte M Deane
Mabs|November 28, 2024
Coactivation of Tie2 and Wnt signaling using an antibody-R-spondin fusion potentiates therapeutic angiogenesis and vessel stabilization in hindlimb ischemiaByungtae Hwang, Min-Young Jeon, Ju-Hong Jang, et al.
Mabs|November 26, 2024
Targeting RGMb interactions: Discovery and preclinical characterization of potent anti-RGMb antibodies blocking multiple ligand bindingsMaria Meira, Aurore Frey, Neila Chekkat, et al.
Mabs|November 28, 2024
Heavy chain-only antibodies with a stabilized human VH in transgenic chickens for therapeutic antibody discoveryChristine N Vuong, Kevin M Reynolds, Gerry S Rivera, et al.
Mabs|October 26, 2024
Practical solutions for overcoming artificial disulfide scrambling in the non-reduced peptide mapping characterization of monoclonal antibodiesAndrew Kleinberg, Yuan Mao, Ning Li
Mabs|October 8, 2024
Seq2scFv: a toolkit for the comprehensive analysis of display libraries from long-read sequencing platformsMarianne Bachmann Salvy, Luca Santuari, Emanuel Schmid-Siegert, et al.
Mabs|July 25, 2024
Rapid depletion of "catch-and-release" anti-ASGR1 antibody in vivoSiva Charan Devanaboyina, Peng Li, Edward L LaGory, et al.
Mabs|July 31, 2024
Assessment and incorporation of in vitro correlates to pharmacokinetic outcomes in antibody developability workflowsTushar Jain, Bianka Prinz, Alexander Marker, et al.
Pageof 184

Showing results (361-370 of 1,833) with videos related to

Sort By:
Pageof 184
Mabs|February 2, 2025
Establishing endotoxin limits to enhance the reliability of in vitro immunogenicity risk assessmentsYun Hee Jeong, Gillian Lennon, Geertruida Veldman, et al.
Mabs|November 15, 2024
Development of a novel, high-throughput imaged capillary isoelectric focusing-Western method to characterize charge heterogeneity of monoclonal antibody heavy and light chainsGangadhar Dhulipala, Alanna Broszeit, Kun Lu, et al.
Mabs|November 29, 2024
Humatch - fast, gene-specific joint humanisation of antibody heavy and light chainsLewis Chinery, Jeliazko R Jeliazkov, Charlotte M Deane
Mabs|November 28, 2024
Coactivation of Tie2 and Wnt signaling using an antibody-R-spondin fusion potentiates therapeutic angiogenesis and vessel stabilization in hindlimb ischemiaByungtae Hwang, Min-Young Jeon, Ju-Hong Jang, et al.
Mabs|November 26, 2024
Targeting RGMb interactions: Discovery and preclinical characterization of potent anti-RGMb antibodies blocking multiple ligand bindingsMaria Meira, Aurore Frey, Neila Chekkat, et al.
Mabs|November 28, 2024
Heavy chain-only antibodies with a stabilized human VH in transgenic chickens for therapeutic antibody discoveryChristine N Vuong, Kevin M Reynolds, Gerry S Rivera, et al.
Mabs|October 26, 2024
Practical solutions for overcoming artificial disulfide scrambling in the non-reduced peptide mapping characterization of monoclonal antibodiesAndrew Kleinberg, Yuan Mao, Ning Li
Mabs|October 8, 2024
Seq2scFv: a toolkit for the comprehensive analysis of display libraries from long-read sequencing platformsMarianne Bachmann Salvy, Luca Santuari, Emanuel Schmid-Siegert, et al.
Mabs|July 25, 2024
Rapid depletion of "catch-and-release" anti-ASGR1 antibody in vivoSiva Charan Devanaboyina, Peng Li, Edward L LaGory, et al.
Mabs|July 31, 2024
Assessment and incorporation of in vitro correlates to pharmacokinetic outcomes in antibody developability workflowsTushar Jain, Bianka Prinz, Alexander Marker, et al.
Pageof 184